Understanding Legal Age Limits for Purchasing E-Cigarettes

Aug.31.2022
The age of purchasing and using electronic cigarettes varies between countries, with the US recently changing to 21 years old. Restrictions aim to prevent underage use.

Over the past decade, electronic cigarettes have experienced rapid development, becoming the most popular category of tobacco products and a common solution for those trying to quit smoking. However, with their increasing popularity has come a problematic group of customers – curious minors. Regulatory agencies and legislators have implemented various strategies to prevent young people from using electronic cigarettes, with the most common approach being age restrictions on purchasing these products.

 

Similar to alcohol, mandating a minimum age for the sale of electronic cigarettes is not a perfect solution, but it remains the most reliable method for reducing youth use. Legislators are tasked with determining the age at which individuals can legally purchase e-cigarettes. However, punishing retailers who violate the law and enforcing the regulations can prove challenging. Mistakes in enforcement may inadvertently increase smoking among young people or adults or contribute to the creation of a black market.

 

In most countries, electronic cigarettes are either regulated as tobacco products or as a separate consumer product category, or are not regulated at all. In some countries, electronic cigarette products are prohibited. In countries where they are regulated, the legal age to purchase electronic cigarettes is usually the same as the legal age of majority. In most countries, this age is 18 years old, but as we will see, the situation varies, for example in the US, the largest electronic cigarette market in the world, the legal age to use electronic cigarettes is 21 years old.

 

What is the legal age for purchasing and using e-cigarettes in the United States?

 

In response to pressure from tobacco control groups and concerned parents, Congress passed the new 21st federal tobacco law in December 2019. The law was included in the year-end federal appropriation bill, signed into law by President Trump on December 20th, and went into effect immediately. While it encompasses both cigarettes and other tobacco products, the driving force behind this legislation was concern over youth use of e-cigarettes.

 

The bill adds a provision to the Food, Drug, and Cosmetic Act stating that it is illegal for any retailer to sell tobacco products to anyone under the age of 21. It mandates that each state enforce age restrictions or risk losing some federal drug abuse grant money. The new law does not penalize individuals under the age of 21 for purchasing, using, or possessing tobacco products (usually referred to as "PUP laws"), but only imposes fines on retailers who sell to underage customers.

 

Advocating for the Tobacco Control Act on the 21st.

 

In 2016, the FDA determined that it was federally prohibited to sell electronic cigarette products to those under 18 years of age. By classifying smokeless devices and e-liquids as tobacco products, they automatically fell under existing federal restrictions. The minimum age for purchasing e-cigarettes has been a core demand of tobacco control activists who have long described the e-cigarette market as a "wild west" in need of FDA regulation. The truth is not quite as exciting: at the time federal action was taken, 48 states already had their own age restrictions in place.

 

The legal age for electronic cigarettes varies across countries worldwide.

 

With the exception of countries that have banned electronic cigarettes and those without regulations surrounding them, the majority of nations simply use the legal age of adulthood to set the minimum age for purchasing electronic cigarette products (as well as other adult products).

 

Some countries have a national legal age but allow individual states or provinces to set a higher legal age. For example, Canada's national minimum age is 18, but many provinces and territories have set the age of 19 as the legal age to purchase e-cigarette products. In Australia, the sale of nicotine-containing products (excluding cigarettes) without a doctor's prescription is illegal, but the use of non-nicotine e-cigarettes is allowed and the purchasing age varies by state.

 

If you plan to bring electronic cigarette products to another country, it is wise to contact the authorities of that country before departing to learn about the latest information on electronic cigarette laws and practices.

 

Countries where the legal age for electronic cigarettes is 18 years old:

 

Belgium, Bhutan, Brazil, Bulgaria, Canada, China, Costa Rica, Croatia, Cyprus, Denmark, Ecuador, England, El Salvador, Estonia, Fiji, Finland, France, Georgia, Germany, Greece, Israel, Italy, Ivory Coast, Lithuania, Luxembourg, Malaysia, Maldives, Malta, Moldova, Netherlands, New Zealand, Norway, Papua New Guinea, Paraguay, Poland, Portugal, San Marino, Saudi Arabia, Scotland, Senegal, Slovenia, South Africa, Sweden, Tajikistan, Togo, Tuvalu, Ukraine, Vietnam, Wales.

 

The legal age for purchasing electronic cigarettes is 19 years old in this country.

 

Jordan, South Korea, and Turkey.

 

Countries where the legal age for e-cigarette consumption is 20 years old:

 

Japan

 

Country with legal vaping age of 21 years old:

 

Ethiopia, Guam, Honduras, the Republic of Palau, the Philippines, and the United States (source: the Johns Hopkins University Global Tobacco Control website, Knowledge-Action-Change Global Tobacco Harm Reduction website, and VAPING360 survey)

 

Who knows when adulthood truly begins?

 

No one knows exactly when adolescence ends or adulthood begins - in fact, it varies for each person. However, lawmakers must decide on a legal age of majority that allows young people to vote, sign contracts, apply for credit, serve in the military, and purchase age-restricted products such as alcohol, tobacco, and other items considered inappropriate for children.

 

Age is always a compromise, but it acknowledges that we allow adults to make many risky choices. The U.S. 21 Tobacco Law is a special law because it considers smoking (and vaping) too risky to the point where cigarettes (and e-cigarettes) must be taken away from young people. Most countries in the world have not found enough evidence to support the necessity of taking such extreme measures.

 

Statement.

 

This article is compiled from third-party information and is for industry exchange and learning purposes only.

 

This article does not represent the views of 2FIRSTS, and the company is unable to confirm the authenticity or accuracy of the content. The translation of this article is solely intended for industry-related exchange and research purposes.

 

Due to limitations in our translation abilities, this article may not exactly reflect the original text. Please refer to the original article for accuracy.

 

2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, or international issues and positions.

 

The compilation of information is the property of the original media and authors. If there is any copyright infringement, please contact us for deletion.

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | Philip Morris Japan Teams Up With Renowned French Audio Brand DEVIALET for Limited-Edition IQOS Priced 60% Above Standard Model
Product | Philip Morris Japan Teams Up With Renowned French Audio Brand DEVIALET for Limited-Edition IQOS Priced 60% Above Standard Model
Philip Morris Japan (PMJ) launched the limited-edition IQOS ILUMA i PRIME Soundsorial Model in collaboration with French audio brand DEVIALET on October 1, 2026. Featuring sound-wave patterns, a silver-and-black finish and a gradient holder, the heated tobacco device is priced at JPY 15,980, including tax, and is available at four IQOS stores in Japan. According to Japanese media citing a PMJ representative, about 1,900 units were allocated to the Japanese retail market. A separate Soundsorial Collection, combining the device with DEVIALET Gemini II earbuds, includes 440 sets allocated to Japan for a membership prize draw.
product
Oct.23
Japan Survey Finds 49.5% Would Cut Tobacco Use if Prices Rise, 64.6% Show Interest in Nicotine-Free Alternatives
Japan Survey Finds 49.5% Would Cut Tobacco Use if Prices Rise, 64.6% Show Interest in Nicotine-Free Alternatives
A September online survey commissioned by Japanese smoking-accessories company Lightec found that 49.5% of respondents would consider reducing tobacco use if prices rose further, while 25.1% would consider switching to cheaper brands and 14.5% would consider using or combining alternatives such as vapes and nicotine-free herbal sticks. Another 64.6% expressed some level of interest in such alternatives. The survey covered 1,088 respondents aged 20 to 70 and was conducted by a company that sells NICOLESS nicotine-free vaping and herbal-stick products, meaning its findings should not be treated as representative of Japan's smoking population.
DATA
Oct.12
Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
An October 2026 review of U.S. state vapor product directories found KUMI 6 SCENIC 50K listed in Louisiana and Nebraska. Louisiana classifies 20 related product entries as “FDA EXEMPTION.” The SCENIC platform is marketed in both conventional nicotine-salt and NoNic6 formulations, each advertised with 22mL e-liquid capacity and up to 50,000 puffs. U.S. wholesaler Midwest Goods listed both versions in August 2025 with a suggested retail price of $19.99 each. The NoNic6 version is associated with 6-methylnicotine and is also marketed by some distributors as “nicotine-free.”
product
Oct.27
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
Former BAT global content lead Andy Parton has left the company and launched Destreza, a London-based AI-native marketing consultancy. Parton previously worked across BAT's New Category brands Vuse, Velo and glo and had also served as Global Brand Lead for Vuse Go. Destreza says it will advise consumer businesses on AI in brand strategy, operating models, capability and agency configuration, using specialist AI agents to support research, strategy and creative development. BAT reported £3.621 billion in New Category revenue in 2025.
Sep.22
FDA Authorizes 24 VELO Nicotine Pouches, Increasing U.S. Authorized Total by 56%
FDA Authorizes 24 VELO Nicotine Pouches, Increasing U.S. Authorized Total by 56%
The U.S. FDA authorized 24 VELO nicotine pouch products from a British American Tobacco subsidiary, raising the total number of authorized products from 43 to 67, a 55.8% increase. The newly authorized 4 mg products include lime and passion fruit flavors and feature certified child-resistant packaging. VELO's first FDA marketing authorization adds BAT to a list previously limited to PMI and Altria products, while bringing the agency's nicotine pouch review pilot total to 47 authorized products.
Oct.30
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26